Cornelis Van't Veer Selected Research

R 715

3/2019

Bradykinin receptor deficiency or antagonism do not impact the host response during gram-negative pneumonia-derived sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cornelis Van't Veer Research Topics

Disease

15	Infections 01/2022 - 05/2005
10	Pneumonia (Pneumonitis) 01/2022 - 08/2014
4	Inflammation (Inflammations) 12/2021 - 04/2013
4	Sepsis (Septicemia) 03/2019 - 05/2005
3	Pneumococcal Pneumonia 12/2014 - 06/2012
2	Bacterial Infections (Bacterial Infection) 05/2022 - 01/2022
2	Peritonitis 12/2021 - 05/2005
2	Asthma (Bronchial Asthma) 01/2021 - 08/2014
1	Bacterial Pneumonia 01/2021
1	Pseudomonas Infections 01/2021
1	Hemorrhage 06/2019
1	Thrombosis (Thrombus) 01/2019
1	Lung Injury 04/2017
1	Pulmonary Tuberculosis 12/2015
1	Tuberculosis (Tuberculoses) 04/2013
1	Melioidosis 07/2012
1	Lyme Disease (Disease, Lyme) 08/2011
1	Tick Bites 01/2011
1	Pancreatitis 05/2005

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2011
3	LipopolysaccharidesIBA 12/2021 - 05/2005
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
2	Agammaglobulinaemia Tyrosine KinaseIBA 05/2022 - 06/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2021
2	DNA Methyltransferase 3BIBA 01/2022 - 01/2021
2	DioxygenasesIBA 12/2021 - 12/2020
2	AllergensIBA 01/2021 - 08/2014
2	Triggering Receptor Expressed on Myeloid Cells-1IBA 12/2015 - 08/2014
2	CytokinesIBA 08/2014 - 05/2005
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Pancreatic Elastase (Elastase)IBA 01/2022
1	FlagellinIBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Interleukin-33IBA 01/2021
1	Zonula Occludens-1 ProteinIBA 12/2020
1	OccludinIBA 12/2020
1	Antisense OligonucleotidesIBA 01/2020
1	C-Type Lectins (C-Type Lectin)IBA 06/2019
1	Purinergic P2Y Receptor AntagonistsIBA 06/2019
1	Clopidogrel (Plavix)FDA Link 06/2019
1	Collagen ReceptorsIBA 06/2019
1	Glycoproteins (Glycoprotein)IBA 06/2019
1	Bradykinin Receptors (Bradykinin Receptor)IBA 03/2019
1	KininsIBA 03/2019
1	icatibantIBA 03/2019
1	R 715IBA 03/2019
1	antithrombin III-protease complexIBA 01/2019
1	Thromboplastin (Tissue Factor)IBA 01/2019
1	InflammasomesIBA 01/2018
1	NLR ProteinsIBA 01/2018
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 04/2017
1	AnticoagulantsIBA 04/2017
1	FibrinIBA 04/2017
1	Myeloid Differentiation Factor 88IBA 01/2017
1	Granzymes (Granzyme)IBA 01/2016
1	Receptor for Advanced Glycation End ProductsIBA 09/2015
1	ChemokinesIBA 08/2014
1	Peptide Hydrolases (Proteases)FDA Link 08/2014
1	Protein CIBA 04/2013
1	Endothelial Protein C ReceptorIBA 04/2013
1	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2012
1	Interleukin-1 Receptor-Associated KinasesIBA 06/2012
1	LectinsIBA 08/2011
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 08/2011
1	Complement System Proteins (Complement)IBA 08/2011
1	AntigensIBA 01/2011
1	AntibodiesIBA 01/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2005
1	Toll-Like Receptor 4IBA 05/2005
1	CeruletideIBA 05/2005

Therapy/Procedure

1	Intravenous Injections 04/2017
1	Injections 05/2005
1	Intraperitoneal Injections 05/2005